FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3145694737> ?p ?o ?g. }

• W3145694737 abstract "Graft-vs. host disease (GVHD), both acute and chronic are among the chief non-relapse complications of allogeneic transplantation which still cause substantial morbidity and mortality despite significant advances in supportive care over the last few decades. The prevention of GVHD therefore remains critical to the success of allogeneic transplantation. In this review we briefly discuss the pathophysiology and immunobiology of GVHD and the current standards in the field which remain centered around calcineurin inhibitors. We then discuss important translational advances in GVHD prophylaxis, approaching these various platforms from a mechanistic standpoint based on the pathophysiology of GVHD including in-vivo and ex-vivo T-cell depletion alongwith methods of selective T-cell depletion, modulation of T-cell co-stimulatory pathways (checkpoints), enhancing regulatory T-cells (Tregs), targeting T-cell trafficking as well as cytokine pathways. Finally we highlight exciting novel pre-clinical research that has the potential to translate to the clinic successfully. We approach these methods from a pathophysiology based perspective as well and touch upon strategies targeting the interaction between tissue damage induced antigens and T-cells, regimen related endothelial toxicity, T-cell co-stimulatory pathways and other T-cell modulatory approaches, T-cell trafficking, and cytokine pathways. We end this review with a critical discussion of existing data and novel therapies that may be transformative in the field in the near future as a comprehensive picture of GVHD prophylaxis in 2020. While calcineurin inhibitors remain the standard, post-transplant eparinsphamide originally developed to facilitate haploidentical transplantation is becoming an attractive alternative to traditional calcinuerin inhibitor based prophylaxis due to its ability to reduce severe forms of acute and chronic GVHD without compromising other outcomes, even in the HLA-matched setting. In addition T-cell modulation, particularly targeting some important T-cell co-stimulatory pathways have resulted in promising outcomes and may be a part of GVHD prophylaxis in the future. Novel approaches including targeting early events in GVHD pathogenesis such as interactions bvetween tissue damage associated antigens and T-cells, endothelial toxicity, and T-cell trafficking are also promising and discussed in this review. GVHD prophylaxis in 2020 continues to evolve with novel exicitng therapies on the horizon based on a more sophisticated understanding of the immunobiology of GVHD." @default.
• W3145694737 created "2021-04-13" @default.
• W3145694737 creator A5043391460 @default.
• W3145694737 creator A5054037976 @default.
• W3145694737 date "2021-04-07" @default.
• W3145694737 modified "2023-10-11" @default.
• W3145694737 title "GVHD Prophylaxis 2020" @default.
• W3145694737 cites W1274344746 @default.
• W3145694737 cites W1499473785 @default.
• W3145694737 cites W1510827637 @default.
• W3145694737 cites W1605124125 @default.
• W3145694737 cites W1776520887 @default.
• W3145694737 cites W1806817428 @default.
• W3145694737 cites W1921369055 @default.
• W3145694737 cites W1966191627 @default.
• W3145694737 cites W1967773389 @default.
• W3145694737 cites W1970070684 @default.
• W3145694737 cites W1971907885 @default.
• W3145694737 cites W1973519172 @default.
• W3145694737 cites W1973836102 @default.
• W3145694737 cites W1977694646 @default.
• W3145694737 cites W1983493560 @default.
• W3145694737 cites W1996392478 @default.
• W3145694737 cites W1996893745 @default.
• W3145694737 cites W1997563789 @default.
• W3145694737 cites W1998633680 @default.
• W3145694737 cites W1999131167 @default.
• W3145694737 cites W2001895625 @default.
• W3145694737 cites W2004068872 @default.
• W3145694737 cites W2007766732 @default.
• W3145694737 cites W2008210335 @default.
• W3145694737 cites W2010732369 @default.
• W3145694737 cites W2011605963 @default.
• W3145694737 cites W2012073875 @default.
• W3145694737 cites W2012940838 @default.
• W3145694737 cites W2021534575 @default.
• W3145694737 cites W2024327060 @default.
• W3145694737 cites W2038116051 @default.
• W3145694737 cites W2039334806 @default.
• W3145694737 cites W2050797092 @default.
• W3145694737 cites W2052605694 @default.
• W3145694737 cites W2055981604 @default.
• W3145694737 cites W2058987824 @default.
• W3145694737 cites W2059608155 @default.
• W3145694737 cites W2060741445 @default.
• W3145694737 cites W2073045132 @default.
• W3145694737 cites W2078346968 @default.
• W3145694737 cites W2081293661 @default.
• W3145694737 cites W2085704445 @default.
• W3145694737 cites W2086030126 @default.
• W3145694737 cites W2088233919 @default.
• W3145694737 cites W2094213721 @default.
• W3145694737 cites W2105294056 @default.
• W3145694737 cites W2116483603 @default.
• W3145694737 cites W2117206796 @default.
• W3145694737 cites W2127419842 @default.
• W3145694737 cites W2127459693 @default.
• W3145694737 cites W2137524068 @default.
• W3145694737 cites W2144491171 @default.
• W3145694737 cites W2144843164 @default.
• W3145694737 cites W2148226248 @default.
• W3145694737 cites W2150800804 @default.
• W3145694737 cites W2164885965 @default.
• W3145694737 cites W2166338481 @default.
• W3145694737 cites W2167739766 @default.
• W3145694737 cites W2232371609 @default.
• W3145694737 cites W2257779930 @default.
• W3145694737 cites W2314998678 @default.
• W3145694737 cites W2317548431 @default.
• W3145694737 cites W239839517 @default.
• W3145694737 cites W2398820891 @default.
• W3145694737 cites W2405988863 @default.
• W3145694737 cites W2460851798 @default.
• W3145694737 cites W2528448343 @default.
• W3145694737 cites W2576068665 @default.
• W3145694737 cites W2578115982 @default.
• W3145694737 cites W2595098826 @default.
• W3145694737 cites W2595371676 @default.
• W3145694737 cites W2595681737 @default.
• W3145694737 cites W2621546725 @default.
• W3145694737 cites W2756066029 @default.
• W3145694737 cites W2766752961 @default.
• W3145694737 cites W2769990542 @default.
• W3145694737 cites W2778252021 @default.
• W3145694737 cites W2780122844 @default.
• W3145694737 cites W2784362457 @default.
• W3145694737 cites W2785331260 @default.
• W3145694737 cites W2793186027 @default.
• W3145694737 cites W2796282781 @default.
• W3145694737 cites W2809859307 @default.
• W3145694737 cites W2885514622 @default.
• W3145694737 cites W2899291216 @default.
• W3145694737 cites W2900744589 @default.
• W3145694737 cites W2913268859 @default.
• W3145694737 cites W2917040403 @default.
• W3145694737 cites W2919700205 @default.
• W3145694737 cites W2923738051 @default.
• W3145694737 cites W2952461883 @default.
• W3145694737 cites W2972226667 @default.
• W3145694737 cites W2979476124 @default.

• next